Skip to main content
Frontiers in Psychiatry logoLink to Frontiers in Psychiatry
. 2025 Dec 12;16:1692267. doi: 10.3389/fpsyt.2025.1692267

Somatic symptom and related disorders in the Arab world: a narrative review of clinical features and care implications

Mario Eid 1, Venise Abi Kheir 2, Maya Bizri 3, Amine Larnaout 4, Samer El Hayek 3,5,*
PMCID: PMC12740862  PMID: 41458018

Abstract

Background

Somatic symptom and related disorders (SSRDs) are prevalent worldwide, but their expression, help-seeking patterns, and management are strongly shaped by cultural context. In the Arab world, where mental health stigma and distinct explanatory models are common, SSRDs remain under-studied despite their clinical and public health significance.

Methods

We conducted a narrative review of 35 studies published through June 2025 on SSRDs in Arab populations. Searches of PubMed, Scopus, and Google Scholar identified observational studies, case reports, and cross-sectional surveys addressing Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) SSRD categories.

Results

Somatic symptoms disorder (SSD) was the most frequently investigated disorder, with prevalence ranging from 12% to 46%. Across studies, female gender, low educational attainment, chronic medical comorbidity, and trauma history were consistent risk factors. Common symptoms included muscle, back, and abdominal pain, often accompanied by depression and anxiety. Illness anxiety disorder, functional neurological symptom disorder, and factitious disorders were less studied but carried important diagnostic, cultural, and service delivery challenges.

Conclusion

SSRDs are common but under-recognized in Arab contexts. Effective management requires early detection in primary care, culturally sensitive communication, and disorder-specific interventions. Future research should broaden the scope beyond SSD, examine longitudinal and trauma-related pathways, and evaluate culturally adapted models of care.

Keywords: somatic symptom disorder, illness anxiety, functional neurological symptom disorder, factitious disorder, Arab countries

1. Introduction

Medically unexplained symptoms (MUS) are persistent bodily complaints for which adequate examination does not reveal sufficiently explanatory structural or other specified pathology (1). MUS are common worldwide and occur at particularly high rates in non-Western cultures and among ethnic minorities in high-income countries (2, 3). Their presentation is influenced by sociocultural factors, including linguistic tendencies to convey distress through bodily idioms and culturally shaped health beliefs (4). Distinct regional patterns have been described: for example, African populations may report heat sensations, numbness, and diffuse pain (5); Spanish primary care patients frequently present with backache (6); and patients in Saudi Arabia often report pain and neurological symptoms (7).

The term somatization denotes the expression of psychological distress through physical symptoms that lack an adequate medical explanation. In earlier classifications, persistent physical symptoms were grouped under “somatoform disorders”, which were defined as physical symptoms suggesting a physical disorder without demonstrable organic findings and with strong evidence of psychological causation (8). With the publication of the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), this category was replaced by “Somatic Symptom and Related Disorders” (SSRDs) (9). The text revision DSM-5-TR includes somatic symptom disorder (SSD), illness anxiety disorder, functional neurological symptom disorder (FNSD), factitious disorder, and factitious disorder imposed on another. Disorders previously grouped under somatization, e.g., body dysmorphic disorder and pain disorder, are now classified separately (10). This updated categorization emphasizes the presence of distressing physical symptoms along with disproportionate thoughts, feelings or behaviors, rather than the absence of medical explanation, and underscores the interplay between physical symptoms and mental health (1).

Globally, population surveys indicate that approximately 26–35% of adults attending primary care meet criteria for a somatoform or SSD, and cross-cultural reviews emphasize that somatization is a universal phenomenon, with differences occurring primarily in symptom expression rather than overall prevalence (11, 12). Given their high prevalence, functional impairment, and complex presentation, SSRDs represent a major yet under-recognized public health concern, particularly in regions where cultural factors strongly influence the expression and interpretation of psychological distress.

The Arab region comprises 22 countries with a combined population of approximately 425 million, nearly 60% of whom are under the age of 25 (13). Psychiatric disorders account for an estimated 5.6% of the total disease burden in the region, with depressive disorders contributing the largest share of disability-adjusted life years (14). Suicide is also a growing concern, with 26,000 deaths reported in the Eastern Mediterranean Region in 2016 (15). Despite this burden, mental health service provision remains limited, averaging 7.3 mental health workers and 4.2 psychiatric beds per 100,000 population, compared with 43.5 and 35, respectively, in Europe (16).

In the Arab world, distinct explanatory models of organic and psychiatric illnesses are common (17, 18). Explanatory models encompass the patient and family’s beliefs about illness causes, personal and social meanings, and expected management. These beliefs often incorporate biomedical, psychological, and supernatural elements and shape treatment outcomes (19). In this regard, cultural, religious, and traditional values play a central role in shaping how mental illness is perceived and expressed in Arab societies (20, 21). Socioeconomic challenges, including poverty, gender inequality, stigma, and limited access to specialized care, further influence health-seeking behaviors and the likelihood of receiving appropriate mental health services (22, 23). These sociocultural and structural factors are particularly relevant to SSRDs, as they can affect both the types of symptoms reported and the diagnostic process. For clinicians working in multicultural settings, understanding such cultural dynamics is crucial, because differences in explanatory models, cultural values, and doctor-patient relationship preferences are known to cause communication problems and misinterpretation of symptoms (24).

Although global evidence indicates broadly comparable prevalence rates for SSRDs, reported figures across studies often diverge because of differences in diagnostic criteria, sampling methods, and cultural interpretations of MUS, rather than genuine epidemiological variation (2529). However, little is known about how these patterns manifest specifically within Arab populations, and no comprehensive review has yet synthesized the available evidence.

The present narrative review addresses this gap by summarizing published research on the prevalence, epidemiological characteristics, and associated factors of SSRDs in Arab countries. It also identifies knowledge gaps and outlines recommendations to guide culturally appropriate clinical practice and policy in the region.

2. Material and methods

Given the heterogeneity of diagnostic labels (e.g., somatoform disorder, somatization, bodily distress, etc.), study designs (e.g., case reports, cross-sectional surveys), populations (primary care, hospital outpatients, community samples, refugees, and students) and outcome measures (prevalence, symptom patterns, risk factors, and comorbidities), a formal systematic review or meta-analysis was not feasible. Instead, a narrative review was conducted, providing a comprehensive descriptive synthesis of the diverse data and integrating the relevant cultural context.

A literature search was conducted in PubMed, MEDLINE, Scopus, and Google Scholar from database inception to June 15, 2025. Search terms included "somatic symptom disorder", “somatoform disorder”, “somatization”, "illness anxiety", "hypochondriasis", "conversion disorder", "functional neurological symptom disorder", and "factitious disorder", in combination with "Arab countries" and the names of individual Arab nations. Reference lists of relevant publications were also screened to identify additional studies. No formal language restrictions were imposed.

Eligible studies met the following criteria: (1) conducted in Arab populations, and (2) addressed SSRDs or related diagnoses consistent with DSM-5-TR categories. Observational studies, cross-sectional studies, and case reports were included to capture both clinical trends and culturally specific presentations. For each eligible study, the following information was extracted: study design, country, setting and participant characteristics; diagnostic criteria and screening instruments; sample size and prevalence estimates; symptom patterns; risk factors and comorbidities; management approaches; and authors’ key conclusions. Findings from the included studies were narratively synthesized.

3. Results

A total of 35 studies conducted across various Arab countries were identified, each addressing a specific subtype or presentation of SSRDs. Of these, 18 studies examined SSD, seven addressed illness anxiety disorder, four investigated FNSD, five focused on factitious disorder, and one described a culture-bound syndrome (Dhat syndrome).

A conceptual framework illustrating the manifestation of SSRDs in Arab populations is presented in Figure 1. This framework integrates DSM-5-TR diagnostic categories with common clinical features and sociocultural determinants specific to the region, offering a contextual lens for interpreting the findings described below.

Figure 1.

Flowchart illustrating DSM-5-TR categories, clinical features in Arab populations, and cultural and healthcare modifiers. Categories include somatic symptom disorder and factitious disorder. Features include female predominance and high comorbidity with depression. Modifiers include mental illness stigma, supernatural beliefs, and poor psychiatric care access.

Somatic symptom and related disorders in the Arab World: conceptual framework. Legend: This conceptual framework illustrates how somatic symptom and related disorders (SSRDs), as classified by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), are expressed and influenced within Arab populations. The left layer outlines the primary diagnostic categories under the SSRDs umbrella: somatic symptom disorder, illness anxiety disorder, functional neurological symptom disorder, and factitious disorder. The middle layer presents the core clinical features frequently observed in Arab populations. These include a predominance among females, common symptom patterns (e.g., musculoskeletal symptoms, headaches), high rates of psychiatric comorbidities such as depression, anxiety, and trauma-related symptoms, and frequent general healthcare visits. The right layer identifies key cultural and systemic modifiers that shape how these disorders are experienced, interpreted, and treated. These include stigma surrounding mental illness, religious or supernatural attributions, and limited access to psychiatric services, among others. This model underscores the necessity of using a culturally informed, biopsychosocial approach to diagnosing and managing SSRDs in Arab contexts.

3.1. Somatic symptom disorder

3.1.1. Study origins and sample sizes

Studies on SSD originated from eight Arab countries: Bahrain (n=1) (30), Kuwait (n=1) (25), Oman (n=2) (31, 32), Palestine (n=2) (33, 34), Qatar (n=4) (3538), Saudi Arabia (n=3) (7, 39, 40), Tunisia (n=1) (41), and the United Arab Emirates (UAE) (n=2) (42, 43). Two studies addressed Syrian refugees (n=2) (44, 45).

Sample sizes varied from 38 (31) to 2,000 participants (32). Details of these studies and their main findings are summarized in Table 1.

Table 1.

Summary of studies discussing somatic symptom disorder in the Arab world.

Study Country Pooled sample Scales used Main findings
Alalawi et al. (32) Oman Adult Omani patients attending healthcare centers in Muscat; n=2,000 Somatic Symptom Scale-8 -The prevalence of SSD was 30.1%.
-SSD was significantly associated with female gender (p<0.001), high school education (p<0001), and the presence of chronic medical comorbidities (p=0.001).
Abdelaziz et al. (30) Bahrain Year 2 and Year 6 medical students at the Arabian Gulf University; n=160 Patient Health Questionnaire (PHQ)-15, PHQ-9, Generalized Anxiety Disorder (GAD)-7 -The prevalence of somatic symptoms was 46%.
-Higher levels of somatic symptoms were found in females compared to males (p<0.05).
-Year 2 students reported higher somatic symptom levels than year 6, but this was not statistically significant.
-Students had notable levels of anxiety (39.4%) and moderate-to-severe depression (18.8%).
Al-Adawi et al. (31) Oman Women diagnosed with undifferentiated somatoform disorder and healthy subjects; n=38 Composite International Diagnostic Interview, tests for neurocognitive functioning, Bradford Somatic Inventory -Significant differences between patients with undifferentiated somatoform disorders and normal healthy subjects were found on tests of working memory and executive functioning (p<0.001), perseverative errors (p<0.001), sleep quality (p<0.001), anxiety (p<0.001), and somatization (Bradford Somatic Inventory 57.0 vs. 27.4, p<0.001).
Alanazi et al. (7) Saudi Arabia Patients at King Abdulaziz Medical City; n=89 -The most prevalent SSRDs were somatization (77.5%), followed by conversion (13.5%), pain disorder (5.6%), and hypochondriasis (3.4%).
-The most common presenting symptoms in the somatization group were pain (56.2%) and neurological symptoms (46.4%).
-53.9% initially presented to the outpatient clinic, while the remaining participants attended the emergency department.
-41.6% of patients received no pharmacological treatment. When received, treatment mainly included antidepressants (46%), anticonvulsants (16.9%), and atypical antipsychotics (11.2%).
Aleyeidi et al. (39) Saudi Arabia Community adults; n=1,377 Somatic Symptom Scale−8, Cyberchondria Severity Scale -52.6% of participants exhibited high cyberchondria/high somatic symptom scores.
-Younger age (p<0.001), female gender (p<0.001), having chronic diseases (p=0.004), lower monthly income (p=0.002), and frequent internet search (p=0.04) were significantly associated with increased severity of cyberchondria and somatic symptoms.
-Affordability and the sense of confidence provided by internet self-diagnosis were key factors influencing self-management intentions in 54.6% and 34.1% of participants, respectively.
Alkhadhari et al. (25) Kuwait Individuals attending primary care clinics in Kuwait; n=1,046 PHQ-Somatic/ Anxiety/ Depression (PHQ-SAD) (comprises PHQ-9, PHQ15, and GAD-7) -42.3% and 64.1% had at least one mental condition and a physical illness, respectively, with 34.4% having a mental-physical comorbidity.
-Somatization was the most common mental condition comorbid with physical illnesses, occurring in 20.8% of cases.
-Somatization score was associated with a higher number of physical illnesses (mean PHQ-9 = 6.8 for no physical illness, 8.5 for one, 9.6 for two, and 11.1 for three or more physical illnesses, p<0.001).
-Patients with asthma had significantly higher somatization scores compared to those with diabetes and hypertension (mean PHQ-9 = 11.8, 8.3, and 8.9, respectively, p<0.01).
Alqahtani & Salmon (40) Saudi Arabia Patients attending primary care; n=224 12- and 28-item versions of the General Health Questionnaire -The prevalence of psychological disorders was 43% and 53%, as per the 12- and 28-item versions of the General Health Questionnaire, respectively.
-The most prevalent psychological morbidities were depression (27%), anxiety (25%), and somatic symptoms (16%).
-The prevalence of somatization was 14%.
-Females reported more somatic symptoms than males (p<0.001).
-The most common presenting symptom was headache.
Bener, Al-Kazaz, et al. (35) Qatar Patients attending primary care; n=1,762 PHQ-15 -The prevalence of somatization, depression, anxiety, and stress was 11.7%, 11.3%, 8.3%, and 18.6%, respectively.
-9.3% of participants had comorbid depression, anxiety, somatization, and stress.
-The most common symptoms among males and females were stomach pain (64.9% and 65.3%, respectively) and pain in arms/legs/joints (51.4% and 43.1%, respectively).
-51.7% and 50% of patients with depression and anxiety, respectively, had somatic symptoms.
-50% and 35.4% of patients with somatoform disorders had symptoms of depression and anxiety, respectively.
Bener, Dafeeah, et al. (36) Qatar Patients attending primary care; n=1,762 PHQ-15 –The prevalence of somatic symptoms was 13% (229 out of 1,762 subjects).
-48.5% had more than four somatic symptoms, and 31.9% had severe symptoms.
-Those with somatic symptoms also had depression (15.3%), anxiety (8.7%), and stress disorders (19.2%).
-Gender differences were found in age group (p=0.001), nationality (p<0.001), and profession (p<0.001)
Bener, Ghuloum, & Burgut (37) Qatar Qatari patients attending primary healthcare centers; n=1,689 12-item General Health Questionnaire,
Clinical interview schedule
-The prevalence of somatoform disorders was 23.9%.
-The most reported symptoms were backache in men (45.5%) and headache in women (55.4%).
-The prevalence of somatoform disorders was slightly higher in females (24.2%) compared to males (23.7%).
-There was a significant difference in somatic symptoms between men and women based on their age group (p=0.031) and level of education (p=0.008), but not their marital status. Specifically, men between 30 and 39 years and women between 40 and 49 years had higher occurrences of symptoms. In addition, housewives and men in administrative posts had higher rates of somatoform disorders compared to other jobs.
-Physical illnesses during childhood (p=0.022) and adulthood (p=0.029) were significantly higher in men with somatoform disorders.
-Psychiatric family history (p=0.012), prolonged depressive reaction (p=0.003), and discontent with social life (p<0.001) were significantly higher in women with somatoform disorders.
Bener, Ghuloum, Al-Mulla, et al. (38) Qatar Qatari patients attending primary n=1,689 12-item General Health Questionnaire, Clinical Interview Schedule -The prevalence of somatization was 12.4%.
-Somatization was significantly more frequent among middle-aged patients, particularly those aged 30–39 years (p=0.01).
-Predictors of somatization: general health (p<0.001) and adverse childhood experiences (p=0.003).
-Most diagnostic categories and the severity of psychiatric illness were higher in patients with psychologization compared to those with somatization.
-No significant differences were observed for gender, marital status, education, or profession.
Borho et al. (44) Syrian refugees Syrian refugees in Germany; n=116 PHQ-15 -The prevalence of somatic distress risk was 49.1%.
-The prevalence of moderate-to-severe distress was 24.1%.
-The most distressing symptoms were back pain (22.4%) and pain in arms/legs/joints (17.2%).
-Factors significantly associated with somatic distress: female gender, higher number of medical visits, traumatic experiences, more different trauma types, and higher depression and anxiety scores (p<0.05).
El-Rufaie et al. (42) United Arab Emirates Patients attending a primary health care center in Al-Ain; n=652 12-item General Health Questionnaire, Clinical Interview Schedule -The prevalence of somatoform disorders was 12%.
-Headache (45%), backache (35%), and abdominal pain (30%) were the most common somatic symptoms.
-Other symptoms included pain in the upper and lower limbs (19%), fatigability (19%), generalized aches and pains (16%), chest pain (15%), pain or discomfort in the throat (9%), and breathlessness (9%).
-26% presented with one symptom, 29% presented with two symptoms, and 45% presented with three or more symptoms.
-The duration of presenting symptoms was 1 year in 23% of patients, 1–2 years in 23%, and >2 years in 48%.
-Symptoms were mild in 18% of patients, moderate in 49%, and severe in 34%.
-There was no statistically significant difference between somatoform disorders and psychologized mental disorders groups in terms of age, gender, marital status, occupation, and smoking habits. However, the educational level was significantly lower among the former group (p=0.03).
Halak & Idris (33) Palestine Visitors to major hospitals in the Hebron Governorate; n=523 Family Risk Factor Scale -Among participants, 299 had psychosomatic conditions.
-Experiences of childhood physical, emotional, and sexual abuse were found to be significant among individuals with psychosomatic disorders.
-This was more observed among males, those aged 31–40 years, divorced parents, those married for more than 11 years, those with 4–5 children compared to fewer than 4 or more than 6, and those with less than secondary school education.
Hiar et al. (41) Tunisia Tunisians exposed to the Arab Spring events; n=60 PHQ-15 -Peri-traumatic dissociation was independently associated with somatic complaints (p=0.03).
-Somatic complaints were independently associated with both 12-month physical and mental quality of life (p=0.019).
-Somatic symptoms significantly mediated the relationship between peri-traumatic dissociation and physical and mental quality of life.
Mahmoud et al. (43) United Arab Emirates Adults residing in the UAE; n=530 Composite International Diagnostic Interview -57.2% of participants suffered from at least one mental disorder, with higher prevalence rates in women than in men (p=0.029).
-Anxiety (56.4%), depression (31.5%), and post-traumatic stress disorder (15.1%) were the most prevalent disorders.
-The prevalence of somatoform disorder was 4%.
McGrath et al. (45) Syrian refugees Syrian refugees in Istanbul, Turkey; n=1,678 PHQ-15 -The prevalence of high somatic distress was 41.7%.
-The most distressing symptoms were pain in arms/legs/joints (38.4%), back pain (38%), and headaches (28%).
-Factors positively associated with somatic distress: female gender (odds ratio OR=2.91, 95%, 95% CI = 2.32-3.63, p<0.001), chronic disease (OR=2.87, 95% CI = 2.28-3.61, p<0.001), depression (OR=3.05, 95% CI = 2.32-4.01, p<0.001), anxiety (OR=4.64, 95% CI = 3.50-6.15, p<0.001), post-traumatic stress disorder (OR=1.75, 95% CI = 1.28-2.39, p<0.001), and having a family member with mental health problems (OR=1.65, 95% CI = 1.30-2.09, p<0.001),
- Factors positively associated with somatic distress: living in an average (OR=0.64, CI = 0.52-0.80, p<0.001) or good/very good (OR=0.53, 95% CI = 0.31-0.88, p=0.015) household economic situation, and higher education (OR=0.95, 95% CI = 0.93-0.98, p=0.001).
Nazzal et al. (34) Palestine Palestinian primary healthcare attendees; n=400 16-point Somatization Scale of the Four-Dimensional Symptom Questionnaire -The prevalence of SSD was 32.5%.
-Muscle pain was the most common symptom (61.5%), followed by back pain (52.3%) and tingling in the fingers (43.8%).
-Factors significantly associated with SSD: female gender (adjusted OR aOR=2.1, 95% CI = 1.2-3.7, p=0.043), chronic diseases (aOR=2.4, 95% CI = 1.3-4.5, p=0.01), high depression scores (aOR=3.3, 95% CI = 2.0-5.5, p<0.001), and high anxiety scores (aOR=2.1, 95% CI = 1.2-3.6, p=0.031).
-Affected patients had a higher frequency of doctor visits compared to healthy individuals (aOR=2.4, 95% CI = 1.4-4.1, p=0.003).

3.1.2. Study settings and populations

Most studies were conducted in primary care settings and involved adults attending primary health care clinics (25, 32, 3438, 40, 42). Other populations included hospital-based patients seeking treatment or follow-up services (7, 33, 43), community-dwelling adults (39, 41), Syrian refugees residing in host countries (44, 45), and medical students (30).

3.1.3. Prevalence

The prevalence of somatic symptoms/somatization ranged from 12% (35, 37, 42) to 46% (30). Conversely, the prevalence of “somatoform disease” ranged from 4% (43) to 32.5% (34).

One study reported high somatic symptom scores in 52.6% of participants (39). Among Syrian refugees, bodily distress was common, ranging from 41.7% (45) to 49.1% (44).

3.1.4. Risk factors

Across studies, female gender was the most frequently reported risk factor (30, 32, 39, 40, 44, 45).

Several studies reported gender-specific patterns: differences in somatic symptoms by age group (35, 37), level of education (38), nationality, and profession (36). Men were more likely to report physical illnesses during both childhood and adulthood, whereas women showed higher rates of psychiatric family history, prolonged depressive reactions, and dissatisfaction with social life (37).

Other significant risk factors included younger age (39), lower education level (32, 42, 45), lower socioeconomic status (39, 45), chronic medical comorbidities (32, 34, 45), positive psychiatric family history (45), and high depression and anxiety scores (34, 44, 45).

Past trauma (44, 45) and trauma-related factors were also prominent. These included childhood abuse, exposure to traumatic events, and emotional neglect (33, 38), with the greatest impact observed in males, individuals aged 31–40 years, those with divorced parents, and those with less than secondary school education (33). In Tunisia, peri-traumatic dissociation was independently associated with somatic complaints one year after the Arab Spring events. Somatic symptoms also mediated the relationship between peri-traumatic dissociation and reduced physical and mental quality of life (41).

3.1.5. Symptomatology

Commonly reported symptoms included pain (7), particularly:

  • Muscle and back pain (34, 37, 42, 44, 45),

  • Stomach pain (35),

  • Aches in arms, legs, and joints (36, 44, 45),

  • Headaches (38, 40) (42, 45).

Two studies found that nearly half of affected individuals reported three or more symptoms (35, 42).

3.1.6. Comorbidity

Somatization was the most prevalent psychiatric condition comorbid with organic illnesses (25). Compared with healthy individuals, those with SSD visited physicians more frequently (34). One study noted that over one-third (41.6%) did not receive pharmacological treatment (7).

Somatization frequently co-occurred with depression and anxiety (36). In addition, patients with undifferentiated somatoform disorder showed lower scores in working memory, executive functioning, and sleep quality, and higher anxiety scores compared to healthy controls (31).

3.2. Illness anxiety disorder

Studies on illness anxiety originated from Egypt (n=2) (46, 47), Jordan (n=1) (48), Lebanon (n=1) (49), Saudia Arabia (n=2) (50, 51), and the UAE (n=2) (46, 52). Details of these studies and their main findings are presented in Table 2.

Table 2.

Summary of studies discussing illness anxiety disorder in the Arab world.

Study Country Pooled sample Scale used Main findings
Abdel Aziz et al. (52) UAE Undergraduate medical students; n=193 Short Health Anxiety Inventory -9.3% of students reached the threshold for clinically significant health anxiety.
-No significant differences in characteristics were found between students with and without health anxiety.
Alsamhori et al. (48) Jordan Medical students; n=1,050 Self-developed questionnaire -9.3% of participants had a high likelihood of developing illness anxiety disorder.
-Among those individuals, 8% stated that fear of illness makes it difficult for them to function in society.
-Students planning to visit a psychiatrist had significantly higher chances of developing illness anxiety (B=2.163, 95% CI = 1.396-3.352; p=0.001).
-No significant differences were observed by gender or by stage of study (clinical vs. preclinical).
Bilani et al. (49) Lebanon Parents of children with cancer; n=105 Illness Cognition Questionnaire – Parent Version, Short Health Anxiety Inventory -The mean parental age was 37.7 years, with most participants being married (94.3%) and mothers (78.1%).
-Children mostly suffered from leukemia and had an average age of 8.4 years.
-21% of parents experienced health anxiety.
-Health anxiety was significantly associated with feelings of helplessness (B=0.222, p=0.021), lower acceptance (B=-0.242, p=0.008), perceived insufficient income (B=-0.238, p=0.021), and personal illness or sickness of a family member/friend (B=0.251, p=0.013).
El-Gabry et al. (46) Egypt, UAE Physicians; n=108 - -34.2% of physicians reported encountering parents with illness anxiety by proxy.
-33.6% reported that parents had a persistent concern that their child had a serious disease that doctors were unable to diagnose.
-The most cited reason for these concerns was an exaggeration of existing symptoms (52.3%).
-The concerned parent was more likely to be the mother in 48.3% of cases.
-24.2% of physicians reported that most parents were unsure of their beliefs.
Ezmeirlly & Farahat (50) Saudi Arabia Medical students; n=271 Short Health Anxiety Inventory, the Medical Students' Disease Perception and Distress Scale -The prevalence of illness anxiety disorder was 17%.
-Younger students aged <22 years (OR=2.31, 95% CI = 1.16-4.60, p=0.02) and those with a history of a physician’s visit within the past 6 months (OR=2.46, 95% CI = 1.25-4.84, p=0.01) were more likely to have illness anxiety disorder.
-The highest concern reported by one fifth of the students who visited a physician in the past 6 months was cancer (22%), followed by heart disease (8%), and infection (8%).
Hawamdeh et al. (51) Saudi Arabia Medical and nursing students; n=216 and 250, respectively Short Health Anxiety Inventory, the Medical Students' Disease Perception and Distress Scale -The prevalence of illness anxiety disorder was 38.8%.
-Medical students had a significantly lower prevalence of illness anxiety compared to nursing students (57.2% vs 17.6%, respectively, p<0.001).
-Fourth-year level nursing students had significantly higher scores than other nursing students (p<0.01).
Terra et al. (47) Egypt Medical students; n=1,173 Short Health Anxiety Inventory, 12-Item Short Form Survey -15.7% of participants experienced clinically significant health anxiety.
-A significant negative correlation was observed between health anxiety and quality of life (r=-0.393, p≤0.05).
-Significant predictors of health anxiety included female gender (OR=1.41, 95% CI = 1.01-1.96, p=0.04) and lack of academic performance satisfaction (OR=1.43, 95% CI = 1.04-1.96, p=0.02).

Sample sizes ranged from 105 (49) to 1,173 participants (47). Populations included parents of children with cancer (49), physicians reporting on illness anxiety by proxy in parents (46), and medical students (47, 48, 5052).

Reported prevalence ranged from 9.3% (52) to 38.8% (51) among medical students, and reached 21% among parents of children with cancer (49).

In medical students, health anxiety was significantly associated with lower quality of life (47), younger age (50), and a planned/recent visit to a doctor/psychiatrist (48, 50), while female gender and lack of academic satisfaction emerged as significant predictors in one study (47). Among parents of children with cancer, health anxiety was significantly associated with feelings of helplessness, lower acceptance, perceived insufficient income, and personal illness or sickness of a family member/friend (49). The most cited explanation for parental fears was an exaggeration of actual existing symptoms (46).

3.3. Functional neurological symptom disorder

Studies on FNSD originated from Oman (n=1) (53), Qatar (n=1) (54), and Saudi Arabia (n=2) (55, 56). Details of these studies and their main findings are presented in Table 3.

Table 3.

Summary of studies discussing functional neurological symptom disorder in the Arab world.

Study Country Pooled sample Scale used Main findings
Chand et al. (53) Oman Children with conversion admitted to Sultan Qaboos University Hospital; n=25 -The most common presentation was conversion disorder with convulsions (68%), followed by conversion disorder with motor symptoms (12%), motor and sensory symptoms (8%), dissociative trance state (8%), and sensory symptoms (4%).
-16% of patients had comorbid epilepsy.
-8% of patients had comorbid depression.
Hamdy et al. (55) Saudi Arabia Patients with seizures; n=341 -PNES was diagnosed in 6 (1.8%) out of 341 patients.
-All patients with PNES were females aged 17–27 years.
Tayeb et al. (56) Saudi Arabia Tertiary neuro-psychiatry referrals; n=473 -Out of 473 patients, 52 (11%) had functional neurological disorder.
-Mean age was 34 years, and 77% were female.
-Family dispute (39%) was the most reported risk factor, followed by sexual abuse (15%).
-The most common symptoms were nonepileptic seizures (61.5%) and abnormal movements (30.8%).
-Pain was reported by 57.7% and cognitive symptoms by 36.5%.
-Symptoms were frequently attributed to supernatural causes (67.3%).
-During the last follow-up visit, 53.9% reported symptom improvement, 21.2% reported no change, 10.2% reported worsening, and 15% were lost to follow-up.
-The proportion of patients without symptom improvement was significantly higher among those with cognitive symptoms (p=0.018).
-The mean number of visits was highest in patients reporting worsening and the lowest was among patients reporting no change (p=0.017).
Wilkins et al. (54) Qatar Patients admitted to the National Health Epilepsy Monitoring Unit; n=113 PHQ-9 -Of 71 confirmed diagnoses, 20 patients had PNES, 46 were diagnosed with epilepsy, and 5 had both disorders.
-Individuals with PNES were significantly more likely to be native Arabs compared to those with epilepsy (p=0.003).
-Patients with PNES also had more frequent seizures (p=0.051), higher mean depression scores on the PHQ-9, and more fatigue (p=0.021)
-The most common referral reason in patients with PNES was recurrent/refractory seizures (p=0.011).

Sample sizes ranged from 25 children with dissociative conversion disorder (53) to 473 adult referrals to a neurology-psychiatry clinic (56). In the latter, the prevalence of FNSD was 11%, with psychogenic non-epileptic seizures (PNES) being the predominant type (56).

In studies focusing on individuals with seizures, the prevalence of PNES ranged from 1.8% (55), to 25 of 71 confirmed seizure diagnoses in an epilepsy monitoring unit in Qatar; this included 20 patients with PNES alone and 5 with both PNES and epilepsy (54).

Risk of FNSD was highest among women and patients reporting family conflict or sexual abuse (56). Compared to those with epilepsy, individuals with PNES were more likely to be native Arabs, to have more frequent seizures, and to report higher depression scores and greater fatigue (54).

3.4. Factitious disorder and other conditions

A total of five case reports addressed factitious disorders in the Arab world. These included one prospective case series from Oman (57) and case reports from Jordan (58), Oman (59), and Saudi Arabia (60, 61). One additional case report discussed Dhat syndrome in Oman (62). Details of these studies, including demographics, clinical presentations, and outcomes, are summarized in Table 4.

Table 4.

Summary of studies discussing factitious disorder and Dhat syndrome in the Arab world.

Study Country Case characteristics Main findings
Al-Habeeb (60) Saudi Arabia Case reports (n=2) of Münchausen in two adults admitted to a psychiatry unit -The first case was that of a 45-year-old female with factitious dermatosis.
-The second case was that of a 39-year-old man with chronic physical symptoms associated with multiple hospitalizations.
Arabi et al. (61) Saudia Arabia Case report of Münchausen by proxy in a male infant -In each case, the child had recurrent episodes of severe hypoglycemia that were unexplained despite extensive investigations for endocrine and metabolic etiologies.
-In each case, the child's attacks were resolved when he was briefly separated from his mother.
-The diagnosis of factitious hypoglycemia imposed on another by proxy was confirmed following a scheduled change of the insulin assay in the laboratory.
Bappal et al. (59) Oman Case report of Münchausen by proxy in a male boy
Bhargava et al. (57) Oman Case series (n=19) with long-term follow-up (two to six years) looking at the profile of Münchausen syndrome at a tertiary care hospital -The prevalence of factitious disorder was 0.2%.
-Out of the 19 patients, 42.1% had hemorrhagic factitious disorders, 15.8% feigned multiple surgical interventions, and 15.8% received a diagnosis of neurological factitious disorders.
-The remaining 26.3% showed signs of minor feigned illnesses.
-Objective "evidence factitia" was present in 68.4% of cases.
-Following treatment, the prognosis was best for those without co-occurring psychiatric disorders
Karadsheh (58) Jordan Case report of Münchausen syndrome in a 16-year-old girl -The patient was admitted to the hospital with sudden bleeding from both eyes.
-Upon examination, blood was observed to pour from her eyes, but physical examination was otherwise regular.
-During the patient's hospitalization, it was noted that the bleeding occurred only when the patient was alone in her room.
-Later, she was observed pricking her fingertips with a hair clip and using it to cover her eyes with blood.
-The patient denied having any psychological problems and did not show up for follow-up after discharge.
MacFarland et al. (62) Oman Case report of Dhat Syndrome in a 26-year-old male -The patient, residing in a rural area, dropped out of university due to a distressing preoccupation with semen loss, which occurred at least once a day.
-He was preoccupied with inadequacy and lack of self-esteem and doubted his masculinity.
-The patient's blood tests were within normal limits.
-Psychometric measures showed elevated scores on indices of hypochondriasis, psychasthenia, and gender role development.
-Implementation of cognitive behavioral therapy, concurrent with a successful marriage proposal, resulted in a gradual resolution of the symptoms.

The case series (n=19) reported a prevalence of factitious disorder of 0.2%, with hemorrhagic presentations being the most common (57). The case reports described Münchausen syndrome in adults (60) and adolescents (58), and Münchausen by proxy in two infants (59, 61). The culture-bound Dhat syndrome case involved a young Omani male and suggested that the condition may be under-recognized in the region (62).

4. Discussion

In the 35 studies included in this review, SSRDs were documented across diverse Arab populations and clinical settings. Prevalence estimates for SSD ranged from 12% to 46%, while illness anxiety disorder and FNSD reached up to 38.8% and 11%, respectively, in specific subgroups. Factitious disorder and rare culture-bound presentations, such as Dhat syndrome, were reported only as isolated cases. These findings broadly align with international data; a systematic review of 32 studies from 24 countries identified a prevalence of at least one type of somatoform disorder between 26.2% and 34.8% in primary care, and up to 49% of individuals reported at least one MUS (12). European population studies likewise suggest that 8% to 20% of adults experience persistent functional symptoms, though prevalence varies by instrument and health-system context (63). Patterns of comorbidity and impairment are also consistent with global evidence: international cohorts demonstrate high rates of co-occurring anxiety and depressive disorders (64), frequent primary-care attendance, and significant work-related disability (65, 66).

Although prevalence patterns were broadly comparable to international data, the research focus within Arab studies remained narrow, emphasizing SSD over other SSRDs. Methodological heterogeneity, small sample sizes, and underrepresentation of certain countries further limited cross-study comparability. Despite these limitations, several cross-cutting themes emerged: (1) a high burden of psychiatric comorbidity, especially depression, anxiety, and trauma-related symptoms; (2) frequent co-occurrence with chronic medical illness; and (3) strong influence of sociocultural factors on symptom expression and help-seeking behavior. These patterns suggest that SSRDs in Arab contexts share core features with global presentations but are shaped by region-specific cultural norms, healthcare structures, and stigma toward mental illness.

4.1. Somatic symptom disorder

SSD was by far the most studied SSRD in Arab populations, with consistent associations with female gender, lower educational attainment, chronic medical conditions, and psychological distress, including depression, anxiety, and trauma-related symptoms. Research has identified a range of potential risk factors for SSD, including female gender (67), sociocultural factors (68), childhood trauma (69), genetic predisposition (70), and specific personality traits (71).

Arab refugees in host countries exhibited high rates of bodily distress, mirroring findings from refugee populations elsewhere (72, 73). This is often linked to cumulative trauma exposure, displacement stressors, socioeconomic hardship, and poor access to continuity of care (74).

Muscle and back pain were the most reported somatic symptoms, and affected individuals had comorbid mental health problems, including depression, anxiety, and trauma-related symptoms. These associations are consistent with global findings (28, 64, 69, 75) and reflect a bidirectional relationship, where psychological distress can intensify somatic symptoms, and persistent somatic symptoms can worsen psychiatric morbidity.

A particularly important finding in the Arab literature is the frequent co-occurrence of SSD with chronic organic illnesses. This complicates diagnosis and management, as clinicians must avoid both missing an underlying physical disorder and over-investigating symptoms that may have a psychogenic component (76). Furthermore, the associated history of trauma and high depression and anxiety scores reinforces the need for integrated medical–psychiatric care. Without such integration, repeated investigations and delayed recognition of underlying distress are likely to persist, increasing both patient burden and healthcare costs.

The optimal management of SSD follows a stepped-care approach grounded in the biopsychosocial model, involving close collaboration among primary-care physicians, relevant medical specialists, and mental health professionals (77). One potential framework for treatment is the CARE MD model. CARE MD is a systematic primary care management framework. It stands for Consultation, Assessment, Regular visits, Empathy, Medical/psychiatric interface, and Do no harm (78, 79). Although the evidence for this model is limited, it builds on established principles of structured care for patients with SSD/SSRD (8082). The model emphasizes scheduled follow-up, legitimization of physical symptom distress, minimization of unnecessary investigations, empathic communication, and coordinated liaison with mental-health services as cornerstones of treatment (78, 79). In Arab contexts, these principles may be particularly relevant given the influence of stigma, supernatural explanatory models (e.g., jinn, evil eye), and the common practice of consulting religious or traditional healers before psychiatric services (83, 84). For example, a primary-care clinician managing a patient who attributes chronic chest pain to the evil eye might apply the CARE MD framework by scheduling regular visits to build trust and continuity, validating the patient’s suffering without endorsing supernatural causation, and engaging family members or religious and community figures, when applicable, to align biomedical and spiritual perspectives. Such culturally attuned use of CARE MD principles can reduce unnecessary investigations and enhance treatment adherence.

4.2. Other somatic symptoms and related disorders

Illness anxiety disorder in Arab populations was most often studied among medical students and caregivers of children with serious illnesses. Among medical students, the elevated rates of illness anxiety are consistent with the “medical student’s disease” phenomenon reported internationally (85), where increased health knowledge and academic pressure heighten health-related concerns and mental health burden (86). This suggests a need for university-based mental health programs that address both general stress management and health anxiety specifically. For parents of children with severe medical conditions, anxiety by proxy has been observed in other cultural settings (87, 88) and may contribute to increased healthcare utilization and child overmedicalization. In the Arab context, where family-centered care is highly valued, pediatric teams may need additional training to detect and address parental anxiety without undermining the therapeutic alliance.

Beyond illness anxiety, other SSRDs present distinct diagnostic and management challenges in the Arab context. FNSD, especially PNES, predominantly presented in young women and was frequently associated with trauma or family conflict. Misdiagnosis as epilepsy was common, which is consistent with global findings and has significant consequences, including unnecessary antiepileptic therapy and delayed psychiatric intervention (8991). Limited access to diagnostic tools such as video-EEG monitoring in many Arab countries may contribute to this problem. Culturally embedded explanatory models, such as attributing seizures to supernatural causes, combined with limited expertise among healthcare providers, can further delay accurate diagnosis and hinder patient engagement in treatment (90, 92). These patterns suggest that in Arab contexts, improving access to neurodiagnostic testing and integrating culturally sensitive psychoeducation into early care pathways could reduce both diagnostic delay and inappropriate treatments.

Factitious disorders, though rare in the literature, present diagnostic and ethical challenges. Their underreporting in Arab research is likely multifactorial, reflecting stigma, medico-legal risks, and limited psychiatric service capacity for prolonged observation. Diagnostic complexity also contributes to under recognition, as differentiating factitious presentations from malingering or conversion disorders often requires multidisciplinary assessment and extended follow-up. Moreover, limited training in consultation-liaison psychiatry within the region may hinder systematic identification and reporting of such cases.

The single report of Dhat syndrome suggests that culture-bound syndromes may exist in Arab contexts but are seldom studied, possibly due to clinicians limited familiarity with such constructs. Beyond Dhat, other culture-bound syndromes have been reported in the region. For instance, Zār spirit possession, observed in North and East Africa and some Middle Eastern societies, manifests as dissociative episodes with behaviors such as shouting, head banging, laughing, or singing, attributed to spirit intrusion (93). Similarly, beliefs in jinn possession are common across Arab societies and may influence how patients interpret somatic and psychiatric symptoms (18). Such explanatory models often lead individuals to seek religious or traditional healing before psychiatric evaluation, potentially delaying diagnosis and treatment. Addressing these conditions requires culturally competent care and collaboration between mental health services and faith-based community resources.

4.3. Risk factors and cultural influences

Female gender emerged as a consistent risk factor for SSRDs, in line with worldwide trends (9496). Several factors may explain this gender variation. To start with, Arab men tend to be less expressive about their illness and distress (94). This could be attributed to specific cultural norms related to the Arab world, wherein men must preserve their sense of masculinity as society defines it. Denying physical symptoms and distress can, therefore, result in men being less likely to present to the clinic with somatization. Moreover, men and women may perceive past medical experiences differently, with the former forgetting about their symptoms more readily than women (94, 97). Other potential explanations include variations in rates of anxiety and mood disorders, as well as abuse and violence between genders (98).

Cultural and religious factors influence not only who presents with SSRDs but also how symptoms are expressed. The Arab culture places a strong emphasis on the body and its sensations, while mental illness is often perceived as a sign of weakness or moral failing. Physical symptoms are, therefore, widely accepted as a legitimate expression of emotional distress. Moreover, religious beliefs and practices may influence the manifestation and interpretation of physical symptoms (99, 100). Consistent with Kleinman’s framework (101), explanatory models observed in Arab contexts often reflect culturally embedded meanings of illness, in which experiences such as jinn influence, the evil eye, or divine testing shape patients’ interpretation of symptoms and expectations of care (102). This cultural framing can also shape help-seeking behavior, as seen in several included studies where patients repeatedly sought biomedical consultations for physical complaints but were reluctant to accept psychiatric referral, and in the literature discussing how individuals may first consult religious or traditional healers rather than mental health professionals (103105).

Clinicians must account for the cultural context when assessing and treating SSRDs in Arab populations. Culturally sensitive interventions, e.g., incorporating religious and spiritual components into treatment, may be effective. These interventions can include integrating religious practices, e.g., prayer, into treatment plans or utilizing culturally specific therapies, such as Hijama (cupping therapy), which is commonly used in Arab countries.

4.4. Implications for practice and policy

The limited availability of mental health services across the Arab region, combined with the central role of primary care in initial presentations, highlights the urgent need for clinician training in early detection and culturally sensitive communication regarding SSRDs. Primary healthcare providers should maintain a high index of suspicion for patients presenting with recurrent unexplained symptoms, to ensure early identification while minimizing unnecessary healthcare utilization. Culturally sensitive communication should be a core competency, helping clinicians explore psychological factors without alienating patients.

For SSD, patient-centered stepped care approaches that integrate the biopsychosocial approach into actual management (8082) can reduce unnecessary investigations, while fostering trust, and improve treatment outcomes. For FNSD, particularly PNES, early diagnosis is critical to improving prognosis (106). During initial consultations, clinicians should conduct thorough mental health assessments that include screening for trauma history, psychosocial stressors, and comorbid psychiatric conditions. Physicians must also be trained in how to deliver the diagnosis clearly and empathetically. Recommended strategies include validating the patient's symptoms, naming the condition, explaining the neurobiological underpinnings (e.g., "the brain temporarily shuts down from overload"), clarifying which treatments are effective, and managing expectations (107, 108). After communicating the diagnosis, the subsequent treatment stage encompasses providing care through a multidisciplinary team that includes a neurologist, psychiatrist, psychologist, rehabilitation medicine physician, and physiotherapist (108). For illness anxiety disorder, particularly among medical students and caregivers, targeted educational interventions can help recalibrate health perceptions and reduce excessive healthcare utilization.

To support clinical implementation, Figure 2 presents a culturally responsive care model tailored to Arab primary care. It integrates diagnostic pathways and screening tools that reflect culturally relevant explanatory models, aiming to enhance patient engagement, therapeutic rapport, and treatment outcomes.

Figure 2.

Flowchart detailing a process for handling patients with unexplained symptoms. It begins with screening using PHQ-15, SSS-8, GAD-7, SHAI, and considering neurologic exams. If SSRD indicators are identified, beliefs and help-seeking behavior are explored. For supernatural beliefs, steps include spiritual validation and transitioning to structured care. For psychologically-minded individuals, actions involve culturally sensitive explanations and initiating CBT or SSRI. Multidisciplinary care includes primary care, psychiatry, neurology, and community support.

A culturally responsive clinical pathway for managing somatic symptom and related disorders in Arab primary care settings. Legend: This flowchart outlines a culturally sensitive, stepwise approach to identifying and managing somatic symptom and related disorders (SSRDs), including somatic symptom disorder, illness anxiety disorder, and functional neurological symptom disorder, in Arab populations. Initial screening is conducted using validated Arabic tools, including the Patient Health Questionnaire-15 (PHQ-15), Somatic Symptom Scale-8 (SSS-8), Generalized Anxiety Disorder-7 (GAD-7), and Short Health Anxiety Inventory (SHAI). A targeted neurological exam can be considered to further assess functional symptoms. Once SSRDs indicators are identified, the clinician explores the patient's explanatory model. For individuals who hold supernatural or culturally bound beliefs (e.g., attribution to jinn, the evil eye, fate, or curses), the care process begins with spiritual and cultural validation, through education, reassurance, and family involvement. This is followed by a gradual introduction of psychosocial explanations, aiming to build trust and prepare for transition to integrated and structured care. For patients more open to psychological models of distress, clinicians can use culturally sensitive language to explain the mind–body connection and initiate treatment such as cognitive behavioral therapy (CBT) or selective serotonin reuptake inhibitors (SSRIs). Incorporating structured reassurance that limits unnecessary investigations while validating suffering is necessary. Both pathways converge on multidisciplinary team care, including collaboration among primary care, psychiatry, neurology, psychology, occupational therapy, social services, and community-based support.

At the policy level, integrating mental health services into primary care, expanding the regional mental health workforce, and developing locally relevant clinical guidelines are urgent priorities. These measures would address the current fragmentation of services, where patients often cycle through repeated biomedical consultations without psychiatric referral. Training primary care providers in culturally informed assessment and communication, drawing on evidence-based approaches such as the WHO mhGAP Intervention Guide (109, 110), can improve early recognition and reduce unnecessary investigations. Public awareness campaigns, ideally co-designed with community and religious leaders, can reduce stigma, encourage help-seeking, and normalize discussion of the mind–body connection, reframing mental health care as compatible with cultural and religious values. Policy should also incentivize research on underrepresented SSRDs and vulnerable groups, such as refugees, medical students, and rural populations, to ensure equitable service development. Investment in longitudinal and intervention studies is essential to inform sustainable, scalable models of care that reflect both the cultural context and the resource realities of the Arab region.

4.5. Limitations

This review has several limitations. The included studies were heterogeneous in design, diagnostic terminology, screening tools, and populations, limiting direct comparison. Most employed cross-sectional designs and self-report measures, reducing diagnostic precision. Small sample sizes and reliance on convenience sampling limited generalizability. Few or no studies examined longitudinal outcomes, cultural explanatory models, or the healthcare system impact of SSRDs. Given these limitations, the review should be interpreted as a broad synthesis rather than a definitive measure of prevalence or causality. Future work should employ validated DSM-5-TR–aligned tools, investigate gender-specific and culturally informed pathways, and assess the effectiveness of culturally adapted interventions in routine care.

5. Conclusion

SSRDs are prevalent in Arab populations, with SSD most frequently studied and marked by high psychiatric comorbidity, overlap with chronic medical illness, and culturally shaped help-seeking patterns. Gender differences and stigma influence symptom expression and delay psychiatric referral. Improving outcomes will require early recognition in primary care, culturally sensitive communication, and patient-centered stepped care approaches. Future research should explore longitudinal outcomes, trauma pathways, and the effectiveness of culturally adapted interventions to guide locally relevant policy and clinical guidelines.

Funding Statement

The author(s) declared that financial support was not received for this work and/or its publication.

Footnotes

Edited by: Hong Wang Fung, The Hong Kong Polytechnic University, Hong Kong SAR, China

Reviewed by: Paul Hüsing, University Medical Center Hamburg-Eppendorf, Germany

Anson Kai Chun Chau, The University of Hong Kong, Hong Kong SAR, China

Author contributions

ME: Conceptualization, Investigation, Writing – original draft, Data curation. VA: Writing – review & editing. MB: Writing – review & editing. AL: Writing – review & editing. SE: Supervision, Writing – review & editing, Conceptualization, Writing – original draft.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Generative AI statement

The author(s) declare that no Generative AI was used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

  • 1. Marks EM, Hunter MS. Medically Unexplained Symptoms: an acceptable term? Br J Pain. (2015) 9:109–14. doi:  10.1177/2049463714535372, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Creed F, Henningsen P, Fink P. Medically unexplained symptoms, somatisation and bodily distress: developing better clinical services. Cambrigde: Cambridge University Press; (2011). [Google Scholar]
  • 3. Wainberg ML, Scorza P, Shultz JM, Helpman L, Mootz JJ, Johnson KA, et al. Challenges and opportunities in global mental health: a research-to-practice perspective. Curr Psychiatry Rep. (2017) 19:28. doi:  10.1007/s11920-017-0780-z, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Lipowski ZJ. Somatization: the concept and its clinical application. Am J Psychiatry. (1988) 145:1358–68. doi:  10.1176/ajp.145.11.1358, PMID: [DOI] [PubMed] [Google Scholar]
  • 5. Ohaeri JU, Odejide OA. Somatization symptoms among patients using primary health care facilities in a rural community in Nigeria. Am J Psychiatry. (1994) 151:728–31. doi:  10.1176/ajp.151.5.728, PMID: [DOI] [PubMed] [Google Scholar]
  • 6. Lobo A, Garcia-Campayo J, Campos R, Marcos G, Perez-Echeverria MJ. Somatisation in primary care in Spain: I. Estimates of prevalence and clinical characteristics. Working Group for the Study of the Psychiatric and Psychosomatic Morbidity in Zaragoza. Br J Psychiatry. (1996) 168:344–8. doi:  10.1192/bjp.168.3.344, PMID: [DOI] [PubMed] [Google Scholar]
  • 7. Alanazi AO, Aljohani RA, Aljohani MF, Alhussaini AA, Alnemer FK, Qasim SS, et al. Epidemiological features and clinical manifestations of patients with somatoform disorder at a tertiary medical city in riyadh, Saudi Arabia. Cureus. (2021) 13:e19799. doi:  10.7759/cureus.19799, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Kallivayalil RA, Punnoose VP. Understanding and managing somatoform disorders: Making sense of non-sense. Indian J Psychiatry. (2010) 52:S240–245. doi:  10.4103/0019-5545.69239, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. APA . Desk reference to the diagnostic criteria from DSM-5. Arlington, VA: American Psychiatric Publishing; (2013). [Google Scholar]
  • 10. APA . Diagnostic and statistical manual of mental disorders: DSM-5-TR (Fifth edition, text revision) (2022). American Psychiatric Association Publishing. Available online at: https://www.psychiatry.org:443/psychiatrists/practice/dsmfiles/559/dsm.html (Accessed July 7, 2025). [Google Scholar]
  • 11. Al Busaidi ZQ. The concept of somatisation: A cross-cultural perspective. Sultan Qaboos Univ Med J. (2010) 10:180–6. doi:  10.18295/2075-0528.1184, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Haller H, Cramer H, Lauche R, Dobos G. Somatoform disorders and medically unexplained symptoms in primary care. Deutsches Ärzteblatt Int. (2015) 112:279–87. doi:  10.3238/arztebl.2015.0279, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. RBAS . Arab human development report 2016: youth and the prospects for human development in a changing reality. In: Regional bureau for arab states (RBAS), human development reports. Washington, DC, USA: United Nations Development Programme (UNDP) (2017). Available online at: https://hdr.undp.org/content/arab-human-development-report-2016-youth-and-prospects-human-development-changing-realityfiles/553/arab-human-development-report-2016-youth-and-prospects-human-development-changing-reality.html (Accessed June 9, 2025). [Google Scholar]
  • 14. GBD 2015 Eastern Mediterranean Region Mental Health Collaborators . The burden of mental disorders in the Eastern Mediterranean region 1990-2015: findings from the global burden of disease 2015 study. Int J Public Health. (2018) 63:25–37. doi:  10.1007/s00038-017-1006-1, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Naghavi M. Global, regional, and national burden of suicide mortality 1990 to 2016: systematic analysis for the Global Burden of Disease Study 2016. BMJ. (2019) 364:l94. doi:  10.1136/bmj.l94, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. WHO . Mental health atlas 2014. In: World health organization, mental health, brain health and substance use (MSD), vol. 69. Geneva, Switzerland: World Health Organization; (2014). Available online at: https://www.who.int/publications/i/item/mental-health-atlas-2014files/547/mental-health-atlas-2014.html (Accessed June 9, 2025). [Google Scholar]
  • 17. Arabiat D, Whitehead L, Al Jabery M, Hamdan-Mansour A, Shaheen A, Abu Sabbah E. Beliefs about illness and treatment decision modelling during ill-health in arabic families. J Multidiscip Healthc. (2021) 14:1755–68. doi:  10.2147/jmdh.S311900, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Lim A, Hoek HW, Blom JD. The attribution of psychotic symptoms to jinn in Islamic patients. Transcultural Psychiatry. (2015) 52:18–32. doi:  10.1177/1363461514543146, PMID: [DOI] [PubMed] [Google Scholar]
  • 19. Dinos S, Ascoli M, Owiti JA, Bhui K. Assessing explanatory models and health beliefs: An essential but overlooked competency for clinicians. BJPsych Adv. (2017) 23:106–14. doi:  10.1192/apt.bp.114.013680 [DOI] [Google Scholar]
  • 20. Fakhr El-Islam M. Arab culture and mental health care. Transcultural Psychiatry. (2008) 45:671–82. doi:  10.1177/1363461508100788, PMID: [DOI] [PubMed] [Google Scholar]
  • 21. Zolezzi M, Alamri M, Shaar S, Rainkie D. Stigma associated with mental illness and its treatment in the Arab culture: A systematic review. Int J Soc Psychiatry. (2018) 64:597–609. doi:  10.1177/0020764018789200, PMID: [DOI] [PubMed] [Google Scholar]
  • 22. Ibrahim NK. Epidemiology of mental health problems in the middle east. In: Laher I, editor. Handbook of healthcare in the arab world. Switzerland: Springer International Publishing; (2021). p. 133–49. doi:  10.1007/978-3-030-36811-1_12 [DOI] [Google Scholar]
  • 23. Zeinoun P, Akl EA, Maalouf FT, Meho LI. The arab region's contribution to global mental health research, (2009–2018): A bibliometric analysis. Front Psychiatry. (2020) 11. Available online at: https://www.frontiersin.org/articles/10.3389/fpsyt.2020.00182 (Accessed July 7, 2025)., PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Stubbe DE. Practicing cultural competence and cultural humility in the care of diverse patients. Focus (Am Psychiatr Publ). (2020) 18:49–51. doi:  10.1176/appi.focus.20190041, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Alkhadhari S, Alsabrrie AO, Ohaeri JU, Varghese R, Zahid MA, Mulsant BH. Mental and physical comorbidity in an Arab primary health care setting. BMC Psychiatry. (2018) 18:313. doi:  10.1186/s12888-018-1903-8, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Garrusi B, Danaei M, Aboosaeidi R. The prevalence and predictive factors of somatization and its relationship with anxiety and depression in Iranian population. J Prev Med Hygiene. (2019) 60:E400–6. doi:  10.15167/2421-4248/jpmh2019.60.4.1006, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Glise K, Ahlborg G, Jonsdottir IH. Prevalence and course of somatic symptoms in patients with stress-related exhaustion: does sex or age matter. BMC Psychiatry. (2014) 14:118. doi:  10.1186/1471-244X-14-118, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Löwe B, Levenson J, Depping M, Hüsing P, Kohlmann S, Lehmann M, et al. Somatic symptom disorder: a scoping review on the empirical evidence of a new diagnosis. psychol Med. (2022) 52:632–48. doi:  10.1017/S0033291721004177, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Wu Y, Tao Z, Qiao Y, Chai Y, Liu Q, Lu Q, et al. Prevalence and characteristics of somatic symptom disorder in the elderly in a community-based population: a large-scale cross-sectional study in China. BMC Psychiatry. (2022) 22:257. doi:  10.1186/s12888-022-03907-1, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Abdelaziz A, Al-Utaybi K, Al-Haris J, Al-Qahtani T, Al-Ghamlas A, Jahrami H, et al. Prevalence and severity of somatic symptoms, depression and anxiety among medical students at the Arabian Gulf University: comparison between second and sixth year. Arab J Psychiatry. (2017) 28:69–75. doi:  10.12816/0036883 [DOI] [Google Scholar]
  • 31. Al-Adawi S, Al-Zakwani I, Obeid YA, Zaidan Z. Neurocognitive functioning in women presenting with undifferentiated somatoform disorders in Oman. Psychiatry Clin Neurosci. (2010) 64:555–64. doi:  10.1111/j.1440-1819.2010.02117.x, PMID: [DOI] [PubMed] [Google Scholar]
  • 32. Alalawi NM, Al Salmani AA, Aljabri MK, Azmi IS, Aljardani MM, Al Mandhari SS, et al. Epidemiology and prevalence of somatic symptom disorder at the primary care level in muscat, Oman: A cross-sectional study. Int J Psychiatry Med. (2022) 58:284–94. doi:  10.1177/00912174221088263, PMID: [DOI] [PubMed] [Google Scholar]
  • 33. Halak E, Idris O. Family Risk Factors among people affected with Psychosomatic Disorders. Arab J Educ Psychol Sci. (2025) 446(6):966–39. doi:  10.21608/jasep.2025.402644 [DOI] [Google Scholar]
  • 34. Nazzal Z, Maraqa B, Abu Zant M, Qaddoumi L, Abdallah R. Somatic symptom disorders and utilization of health services among Palestinian primary health care attendees: a cross-sectional study. BMC Health Serv Res. (2021) 21:615. doi:  10.1186/s12913-021-06671-2, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Bener A, Al-Kazaz M, Ftouni D, Al-Harthy M, Dafeeah EE. Diagnostic overlap of depressive, anxiety, stress and somatoform disorders in primary care. Asia-Pacific Psychiatry: Off J Pacific Rim Coll Psychiatrists. (2013) 5:E29–38. doi:  10.1111/j.1758-5872.2012.00215.x, PMID: [DOI] [PubMed] [Google Scholar]
  • 36. Bener A, Dafeeah EE, Chaturvedi SK, Bhugra D. Somatic symptoms in primary care and psychological comorbidities in Qatar: Neglected burden of disease. Int Rev Psychiatry. (2013) 25:100–6. doi:  10.3109/09540261.2012.730993, PMID: [DOI] [PubMed] [Google Scholar]
  • 37. Bener A, Ghuloum S, Al-Mulla AAK, Al-Marri S, Hashim MS, Elbagi I-EA. Prevalence of somatisation and psychologisation among patients visiting primary health care centres in the State of Qatar. Libyan J Med. (2010) 5:5266–73. doi:  10.3402/ljm.v3405i3400.5266, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Bener A, Ghuloum S, Burgut FT. Gender differences in prevalence of somatoform disorders in patients visiting primary care centers. J Primary Care Community Health. (2010) 1:37–42. doi:  10.1177/2150131909353333, PMID: [DOI] [PubMed] [Google Scholar]
  • 39. Aleyeidi N, Fayed A, Alnowaiser G, Aldubayyan R, Alfahhad L, Alhosaini J, et al. Cyberchondria, somatic symptoms, and internet-based self-diagnosis among the Saudi population. Sci Rep. (2025) 15:18208. doi:  10.1038/s41598-025-02612-9, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Alqahtani MM, Salmon P. Prevalence of somatization and minor psychiatric morbidity in primary healthcare in Saudi Arabia: a prelimininary study in Asir region. J Family Community Med. (2008) 15:27–33. Available online at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377053/., PMID: [PMC free article] [PubMed] [Google Scholar]
  • 41. Hiar S, Thomas CL, Hinton DE, Salles J, Goutaudier N, Olliac B, et al. Somatic symptoms mediate the relationship between trauma during the arab spring and quality of life among Tunisians. J Nervous Ment Dis. (2016) 204:153–5. doi:  10.1097/NMD.0000000000000446, PMID: [DOI] [PubMed] [Google Scholar]
  • 42. El-Rufaie OEF, Al-Sabosy MMA, Bener A, Abuzeid MSO. Somatized mental disorder among primary care arab patients: I. prevalence and clinical and sociodemographic characteristics. J Psychosomatic Res. (1999) 46:549–55. doi:  10.1016/S0022-3999(98)00101-9, PMID: [DOI] [PubMed] [Google Scholar]
  • 43. Mahmoud I, Saravanan C. Prevalence of mental disorders and the use of mental health services among the adult population in United Arab Emirates. Asian J Epidemiol. (2020) 13:12–9. doi:  10.3923/aje.2020.12.19 [DOI] [Google Scholar]
  • 44. Borho A, Morawa E, Schmitt GM, Erim Y. Somatic distress among Syrian refugees with residence permission in Germany: analysis of a cross-sectional register-based study. BMC Public Health. (2021) 21:896. doi:  10.1186/s12889-021-10731-x, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. McGrath M, Acarturk C, Roberts B, Ilkkursun Z, Sondorp E, Sijbrandij M, et al. Somatic distress among Syrian refugees in Istanbul, Turkey: A cross-sectional study. J Psychosomatic Res. (2020) 132:109993. doi:  10.1016/j.jpsychores.2020.109993, PMID: [DOI] [PubMed] [Google Scholar]
  • 46. El-Gabry DA, Aziz KA, Al-Hosani MH, Aljneibi MK, Shouma A, Zeid DA, et al. Frequency of illness anxiety (hypochondriasis) by proxy encountered by doctors in parents towards their children. Ann Clin Psychiatry: Off J Am Acad Clin Psychiatrists. (2022) 34:254–62. doi:  10.12788/acp.0083, PMID: [DOI] [PubMed] [Google Scholar]
  • 47. Terra M, Baklola M, Mansour LS, Darwish NE, Badr ME, Alghazali AA, et al. The association of health anxiety with quality of life among medical students in Egypt: Myth or Menace? BMC Psychiatry. (2024) 24:895. doi:  10.1186/s12888-024-06313-x, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Alsamhori JF, Rihani J, Shaban L, Omeish R, Alsamhori ARF, Alsamhori AF, et al. Illness anxiety symptoms among medical students in Jordan: a cross-sectional study. Middle East Curr Psychiatry. (2025) 32:58. doi:  10.1186/s43045-025-00551-9 [DOI] [Google Scholar]
  • 49. Bilani N, Jamali S, Chahine A, Zorkot M, Homsi M, Saab M, et al. Illness cognition and health anxiety in parents of children with cancer. J Psychosocial Oncol. (2019) 37:713–28. doi:  10.1080/07347332.2019.1600629, PMID: [DOI] [PubMed] [Google Scholar]
  • 50. Ezmeirlly HA, Farahat FM. Illness anxiety disorder and perception of disease and distress among medical students in western Saudi Arabia. Saudi Med J. (2019) 40:1144–9. doi:  10.15537/smj.2019.11.24654, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Hawamdeh S, Moussa FL, Al-Rawashdeh S, Hawamdih SA, Moussa ML. Illness anxiety disorder and distress among female medical and nursing students. Clin Pract Epidemiol Ment Health. (2023) 19:e17450179277976. doi:  10.2174/0117450179277976231115070100, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Abdel Aziz K, Stip E, Al-Sanadi A, Al-Shamsi A, Al-Sharqi H, Eisa Al-Zaabi M, et al. Prevalence and correlates of health anxiety among medical students: a cross-sectional study from the United Arab Emirates. Middle East Curr Psychiatry. (2023) 30:3. doi:  10.1186/s43045-022-00273-2 [DOI] [Google Scholar]
  • 53. Chand SP, Koul R, Al Hussaini AA. Conversion and dissociative disorders in the Sultanate of Oman. J Am Acad Child Adolesc Psychiatry. (2001) 40:869–70. doi:  10.1097/00004583-200108000-00005, PMID: [DOI] [PubMed] [Google Scholar]
  • 54. Wilkins SS, Mesraoua B, Palomo GA, Al Hail H, Salam A, Melikyan G, et al. Characteristics of patients with confirmed epilepsy and psychogenic nonepileptic seizures in Qatar. Epilepsy Behav. (2018) 85:218–21. doi:  10.1016/j.yebeh.2018.06.014, PMID: [DOI] [PubMed] [Google Scholar]
  • 55. Hamdy NA, Alamgir MJ, Mohammad EGE, Khedr MH, Fazili S. Profile of epilepsy in a regional hospital in al qassim, Saudi Arabia. Int J Health Sci. (2014) 8:247–55. Available online at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257360/., PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Tayeb HO. Functional neurological disorder in Saudi Arabia: A retrospective study. Int J Psychiatry Med. (2023) 59:569–82. doi:  10.1177/00912174231215908, PMID: [DOI] [PubMed] [Google Scholar]
  • 57. Bhargava D, Al-Abri R, Rizvi SGA, Al Okbi MH, Bhargava K, Al-Adawi S. Phenomenology and outcome of factitious disorders in otolaryngology clinic in Oman. Int J Psychiatry Med. (2007) 37:229–40. doi:  10.2190/3175-282H-11U4-1U07, PMID: [DOI] [PubMed] [Google Scholar]
  • 58. Karadsheh MF. Bloody tears: A rare presentation of munchausen syndrome case report and review. J Family Med Primary Care. (2015) 4:132–4. doi:  10.4103/2249-4863.152271, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Bappal B, George M, Nair R, Khusaiby SA, De Silva V. Factitious hypoglycemia: a tale from the Arab world. Pediatrics. (2001) 107:180–1. doi:  10.1542/peds.107.1.180, PMID: [DOI] [PubMed] [Google Scholar]
  • 60. Al-Habeeb TA. Factitious disorder in Saudi Arabia: A report of two cases. J Family Community Med. (1999) 6:49–52. Available online at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437074/., PMID: [PMC free article] [PubMed] [Google Scholar]
  • 61. Arabi H, Babiker A, Awadalla AM, Ababneh F, AlMuneef MA. Factitious hypoglycemia in an infant with undetectable exogenous insulin by a commercial insulin immunoassay: A diagnostic pitfall. Cureus. (2023) 15:e33224. doi:  10.7759/cureus.33224, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. MacFarland AS, Al-Maashani M, Al Busaidi Q, Al-Naamani A, El-Bouri M, Al-Adawi S. Culture-specific pathogenicity of dhat (Semen loss) syndrome in an arab/islamic society, Oman. Oman Med J. (2017) 32:251–5. doi:  10.5001/omj.2017.47, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Rometsch C, Mansueto G, Maas Genannt Bermpohl F, Martin A, Cosci F. Prevalence of functional disorders across Europe: a systematic review and meta-analysis. Eur J Epidemiol. (2024) 39:571–86. doi:  10.1007/s10654-024-01109-5, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Creed F, Barsky A. A systematic review of the epidemiology of somatisation disorder and hypochondriasis. J Psychosomatic Res. (2004) 56:391–408. Available online at: https://research.manchester.ac.uk/en/publications/a-systematic-review-of-the-epidemiology-of-somatisation-disorder-files/719/a-systematic-review-of-the-epidemiology-of-somatisation-disorder-.html (Accessed July 7, 2025)., PMID: [DOI] [PubMed] [Google Scholar]
  • 65. Ferrari S, Galeazzi GM, Mackinnon A, Rigatelli M. Frequent attenders in primary care: impact of medical, psychiatric and psychosomatic diagnoses. Psychother Psychosom. (2008) 77:306–14. doi:  10.1159/000142523, PMID: [DOI] [PubMed] [Google Scholar]
  • 66. Hoedeman R, Blankenstein AH, Krol B, Koopmans PC, Groothoff JW. The contribution of high levels of somatic symptom severity to sickness absence duration, disability and discharge. J Occup Rehabil. (2010) 20:264–73. doi:  10.1007/s10926-010-9239-3, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67. Ballering AV, Bonvanie IJ, Olde Hartman TC, Monden R, Rosmalen JGM. Gender and sex independently associate with common somatic symptoms and lifetime prevalence of chronic disease. Soc Sci Med. (2020) 53:112968. doi:  10.1016/j.socscimed.2020.112968, PMID: [DOI] [PubMed] [Google Scholar]
  • 68. Kirmayer LJ, Sartorius N. Cultural models and somatic syndromes. Psychosomatic Med. (2007) 69:832–40. doi:  10.1097/PSY.0b013e31815b002c, PMID: [DOI] [PubMed] [Google Scholar]
  • 69. Afari N, Ahumada SM, Wright LJ, Mostoufi S, Golnari G, Reis V, et al. Psychological trauma and functional somatic syndromes: A systematic review and meta-analysis. Psychosomatic Med. (2014) 76:2–11. doi:  10.1097/PSY.0000000000000010, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70. Gillespie NA, Zhu G, Heath AC, Hickie IB, Martin NG. The genetic aetiology of somatic distress. psychol Med. (2000) 30:1051–61. doi:  10.1017/s0033291799002640, PMID: [DOI] [PubMed] [Google Scholar]
  • 71. Claassen-van Dessel N, van der Wouden JC, Hoekstra T, Dekker J, van der Horst HE. The 2-year course of Medically Unexplained Physical Symptoms (MUPS) in terms of symptom severity and functional status: results of the PROSPECTS cohort study. J Psychosomatic Res. (2018) 104:76–87. doi:  10.1016/j.jpsychores.2017.11.012, PMID: [DOI] [PubMed] [Google Scholar]
  • 72. Lien L, Claussen B, Hauff E, Thoresen M, Bjertness E. Bodily pain and associated mental distress among immigrant adolescents. Eur Child Adolesc Psychiatry. (2005) 14:371–5. doi:  10.1007/s00787-005-0484-5, PMID: [DOI] [PubMed] [Google Scholar]
  • 73. Rometsch C, Denkinger JK, Engelhardt M, Windthorst P, Graf J, Gibbons N, et al. Pain, somatic complaints, and subjective concepts of illness in traumatized female refugees who experienced extreme violence by the “Islamic State” (IS). J Psychosomatic Res. (2020) 130:109931. doi:  10.1016/j.jpsychores.2020.109931, PMID: [DOI] [PubMed] [Google Scholar]
  • 74. Rohlof HG, Knipscheer JW, Kleber RJ. Somatization in refugees: a review. Soc Psychiatry Psychiatr Epidemiol. (2014) 49:1793–804. doi:  10.1007/s00127-014-0877-1, PMID: [DOI] [PubMed] [Google Scholar]
  • 75. Shidhaye R, Mendenhall E, Sumathipala K, Sumathipala A, Patel V. Association of somatoform disorders with anxiety and depression in women in low- and middle-income countries: A systematic review. Int Rev Psychiatry (Abingdon England). (2013) 25:65–76. doi:  10.3109/09540261.2012.748651, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76. Cooper A, Abbass A, Zed J, Bedford L, Sampalli T, Town J. Implementing a psychotherapy service for medically unexplained symptoms in a primary care setting. J Clin Med. (2017) 6:109. Available online at: https://www.mdpi.com/2077-0383/6/12/109 (Accessed July 7, 2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77. Henningsen P. Management of somatic symptom disorder. Dialogues Clin Neurosci. (2018) 20:23–31. doi:  10.31887/DCNS.2018.20.1/phenningsen, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78. Hartman T, Borghuis M, Lucassen P, Van de Laar F, Speckens A, Van Weel C. Medically unexplained symptoms, somatisation disorder and hypochondriasis: course and prognosis. A systematic review. J Psychosomatic Res. (2009) 66:363–77. doi:  10.1016/j.jpsychores.2008.09.018, PMID: [DOI] [PubMed] [Google Scholar]
  • 79. Robert MM. Somatization in the primary care setting. Psychiatr Times. (2006) 23. Available online at: https://www.psychiatrictimes.com/view/somatization-primary-care-setting (Accessed June 6, 2025). [Google Scholar]
  • 80. Henningsen P, Zipfel S, Sattel H, Creed F. Management of functional somatic syndromes and bodily distress. Psychother Psychosom. (2018) 87:12–31. doi:  10.1159/000484413, PMID: [DOI] [PubMed] [Google Scholar]
  • 81. Nair SS, Kwan SC, Ng CWM, Teo DCL. Approach to the patient with multiple somatic symptoms. Singapore Med J. (2021) 62:252–8. doi:  10.11622/smedj.2021059, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82. Röhricht F, Green C, Filippidou M, Lowe S, Power N, Rassool S, et al. Integrated care model for patients with functional somatic symptom disorder – a co-produced stakeholder exploration with recommendations for best practice. BMC Health Serv Res. (2024) 24:698. doi:  10.1186/s12913-024-11130-9, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83. Alqasir A, Ohtsuka K. The impact of religio-cultural beliefs and superstitions in shaping the understanding of mental disorders and mental health treatment among arab muslims. J Spirituality Ment Health. (2024) 26:279–302. doi:  10.1080/19349637.2023.2224778 [DOI] [Google Scholar]
  • 84. Khoury B, Rafeh M, Bou Dargham Z. Traditional healing for physical and mental problems in the Arab region: past and current practices. BJPsych Int. (2024) 21:44–6. doi:  10.1192/bji.2024.3, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85. Azuri J, Ackshota N, Vinker S. Reassuring the medical students’ disease – Health related anxiety among medical students. Med Teacher. (2010) 32:e270–5. doi:  10.3109/0142159X.2010.490282, PMID: [DOI] [PubMed] [Google Scholar]
  • 86. Eley DS, Slavin SJ. Medical student mental health – the intransigent global dilemma: Contributors and potential solutions. Med Teacher. (2024) 46:156–61. doi:  10.1080/0142159X.2023.2279909, PMID: [DOI] [PubMed] [Google Scholar]
  • 87. Panepinto JA, Hoffmann RG, Pajewski NM. The effect of parental mental health on proxy reports of health-related quality of life in children with sickle cell disease. Pediatr Blood Cancer. (2010) 55:714–21. doi:  10.1002/pbc.22651, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88. Pinquart M. Meta-analysis of anxiety in parents of young people with chronic health conditions. J Pediatr Psychol. (2019) 44:959–69. doi:  10.1093/jpepsy/jsz024, PMID: [DOI] [PubMed] [Google Scholar]
  • 89. Jungilligens J, Michaelis R, Popkirov S. Misdiagnosis of prolonged psychogenic non-epileptic seizures as status epilepticus: epidemiology and associated risks. J Neurology Neurosurg &amp; Psychiatry. (2021) 92:1341. doi:  10.1136/jnnp-2021-326443, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90. Kanemoto K, LaFrance WC, Jr., Duncan R, Gigineishvili D, Park S-P, Tadokoro Y, et al. PNES around the world: Where we are now and how we can close the diagnosis and treatment gaps—an ILAE PNES Task Force report. Epilepsia Open. (2017) 2:307–16. doi:  10.1002/epi4.12060, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91. Liampas A, Markoula S, Zis P, Reuber M. Psychogenic non-epileptic seizures (PNES) in the context of concurrent epilepsy – making the right diagnosis. Acta Epileptologica. (2021) 3:23. doi:  10.1186/s42494-021-00057-x [DOI] [Google Scholar]
  • 92. Pretorius C. Barriers and facilitators to reaching a diagnosis of PNES from the patients’ perspective: Preliminary findings. Seizure. (2016) 38:1–6. doi:  10.1016/j.seizure.2016.03.007, PMID: [DOI] [PubMed] [Google Scholar]
  • 93. Mianji F, Semnani Y. Zār spirit possession in Iran and african countries: group distress, culture-bound syndrome or cultural concept of distress? Iran J Psychiatry. (2015) 10:225–32. [PMC free article] [PubMed] [Google Scholar]
  • 94. Barsky AJ, Peekna HM, Borus JF. Somatic symptom reporting in women and men. J Gen Internal Med. (2001) 16:266–75. doi:  10.1046/j.1525-1497.2001.00229.x, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95. Faravelli C, Salvatori S, Galassi F, Aiazzi L, Drei C, Cabras P. Epidemiology of somatoform disorders: a community survey in Florence. Soc Psychiatry Psychiatr Epidemiol. (1997) 32:24–9. doi:  10.1007/BF00800664, PMID: [DOI] [PubMed] [Google Scholar]
  • 96. Rief W, Mewes R, Martin A, Glaesmer H, Brähler E. Evaluating new proposals for the psychiatric classification of patients with multiple somatic symptoms. Psychosomatic Med. (2011) 73:760–8. doi:  10.1097/PSY.0b013e318234eff6, PMID: [DOI] [PubMed] [Google Scholar]
  • 97. van Wijk CM, Kolk AM. Sex differences in physical symptoms: the contribution of symptom perception theory. Soc Sci Med. (1997) 45:231–46. doi:  10.1016/s0277-9536(96)00340-1, PMID: [DOI] [PubMed] [Google Scholar]
  • 98. Yu S. Uncovering the hidden impacts of inequality on mental health: a global study. Trans Psychiatry. (2018) 8:98. doi:  10.1038/s41398-018-0148-0, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99. Al-Krenawi A, Graham JR. Culturally sensitive social work practice with Arab clients in mental health settings. Health Soc Work. (2000) 25:9–22. doi:  10.1093/hsw/25.1.9, PMID: [DOI] [PubMed] [Google Scholar]
  • 100. Sabry WM, Vohra A. Role of Islam in the management of Psychiatric disorders. Indian J Psychiatry. (2013) 55:S205–14. doi:  10.4103/0019-5545.105534, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101. Kleinman A. Patients and healers in the context of culture: An exploration of the borderland between anthropology, medicine, and psychiatry (Vol. 3). Berkeley & Los Angeles, CA: Univ of California Press; (1980). [Google Scholar]
  • 102. Rassool GH. Evil eye, jinn possession, and mental health issues: An Islamic perspective. London & New York: Routledge; (2018). [Google Scholar]
  • 103. Alhorany A. Attitudes toward Help-seeking Counseling, Stigma in Arab context: A Systematic Literature Review. Malays J Med Health Sci. (2019) 15:160–7. [Google Scholar]
  • 104. Fekih-Romdhane F, Daher-Nashif S, Stambouli M, Alhuwailah A, Helmy M, Shuwiekh HAM, et al. Mental illness stigma as a moderator in the relationship between religiosity and help-seeking attitudes among Muslims from 16 Arab countries. BMC Public Health. (2023) 23:1671. doi:  10.1186/s12889-023-16622-7, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105. Lim A, Hoek HW, Ghane S, Deen M, Blom JD. The attribution of mental health problems to jinn: an explorative study in a transcultural psychiatric outpatient clinic. Front Psychiatry. (2018) 9:3389/fpsyt.2018.00089. doi:  10.3389/fpsyt.2018.00089, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106. Gelauff J, Stone J. Prognosis of functional neurologic disorders. In: Handbook of clinical neurology, vol. 139. Amsterdam, Netherlands: Elsevier; (2016). p. 523–41. doi:  10.1016/B978-0-12-801772-2.00043-6, PMID: [DOI] [PubMed] [Google Scholar]
  • 107. Hall-Patch L, Brown R, House A, Howlett S, Kemp S, Lawton G, et al. Acceptability and effectiveness of a strategy for the communication of the diagnosis of psychogenic nonepileptic seizures. Epilepsia. (2010) 51:70–8. doi:  10.1111/j.1528-1167.2009.02099.x, PMID: [DOI] [PubMed] [Google Scholar]
  • 108. Perjoc R-S, Roza E, Vladacenco OA, Teleanu DM, Neacsu R, Teleanu RI. Functional neurological disorder–old problem new perspective. Int J Environ Res Public Health. (2023) 20:1099. doi:  10.3390/ijerph20021099, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109. Raghuram H, Rajguru AJ, Pathiyil MM, Brahmbhatt A, Bhan A, Spagnolo J, et al. Characterizing modifications to the mental health gap action programme (mhGAP) intervention guide during implementation in low- and middle-income countries using the framework for reporting adaptations and modifications to evidence-based interventions: a systematic review of reviews. Int J Ment Health Syst. (2025) 19:20. doi:  10.1186/s13033-025-00671-z, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110. Roxanne K, Jessica S, Graham T. WHO mental health gap action programme (mhGAP) intervention guide: updated systematic review on evidence and impact. Evidence Based Ment Health. (2021) 24:124–30. doi:  10.1136/ebmental-2021-300254, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Frontiers in Psychiatry are provided here courtesy of Frontiers Media SA

RESOURCES